Law360, New York ( July 8, 2015, 10:15 AM EDT) -- The Hart-Scott-Rodino Antitrust Improvements Act of 1976 is poised to take center stage in a takeover battle being played out between two pharmaceutical companies, Teva Pharmaceutical Industries Ltd. and Mylan NV. At issue is whether the companies are sufficiently "foreign" such that acquisition of a noncontrolling stake — even when valued well in excess of the HSR Act's dollar threshold — does not trigger mandatory premerger reporting....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.